| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.03 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.07 | 0.03 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.07 | 0.03 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.03 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.092 | 0.03 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.03 |